D&T Subcommittee Meeting 12 March 2018

posted Jun 17, 2018, 7:26 PM by Chong Ching Wern   [ updated Jun 19, 2018, 7:51 PM ]
 
 No.


 Drug Name

 Decision
 
 1)

 Diacerein 50mg Capsules
 (Artrodar)


 Rejected.

 
 2)

 Fosfomycin Trometamol 3gm Sachet
 (Monurol)


 Rejected.


 
 3)

 Interferon Alfa 2A 135mcg and 180mcg Injection 
 (Pegasys)


 Agreed to add Hematologist as prescriber with restrictions.
 
 4)

 Ketoprofen 30mg Transdermal Patch 

 Rejected.

 
 5)

 Cefuroxime 4mg/0.4mL Intracameral Injection
 

 Accepted as Standard Formulary.

 
 6)

 Sodium Picosulfate 10mg Magnesium Oxide 3.5gm
 Anhydrous Citric Acid 12gm
 (Pico-Salax)
 

 Accepted as Standard Formulary for pediatrics only.

 
 7)

 Naltrexone 50mg Tablet
 

 Deleted.

 
 8)

 Peg-Filgrastin 6mg/0.6mL Injection
 (Peglasta)
 

 Deleted.

 
 9)

 Imipenem 500mg Cilastatin 500mg Injection
 

 Deleted.


Disclaimer: 
For new drug request, physical stock availability will depend on procurement processes. 
Tender items will take about 3-6 months, non tender items will take about 1-3 months. 
Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.